Inicio › Enfermedad cardiovascular › Carolina del Norte › Winston-Salem
Ensayos clínicos de Enfermedad cardiovascular en Winston-Salem, NC
14 estudios para Enfermedad cardiovascular buscan participantes en centros de Winston-Salem y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
ReclutandoFase 4
- Novant Health Forsyth Medical Center, Winston-Salem
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Reclutando
- Wake Forest University Health Sciences, Winston-Salem
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
ReclutandoFase 3
- Wake Forest University Health Sciences-Winston-Salem-61707, Winston-Salem
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Reclutando
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
ReclutandoFase 3
- Clinical Trial Site, Winston-Salem
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
ReclutandoFase 3
- Wake Forest University Baptist Medical Center, Winston-Salem
- Wake Forest University Baptist Medical Center, Winston-Salem
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
ReclutandoFase 4Se aceptan voluntarios sanos
- Wake Forest Baptist Hospital-Cardiology, Winston-Salem
- Wake Forest Hospital - Geriatrics, Winston-Salem
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
ReclutandoFase 1 tempranaSe aceptan voluntarios sanos
- Wake Forest University Health Sciences, Winston-Salem
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
ReclutandoEstudio observacional
- Wake Forest University Health Sciences, Winston-Salem
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
ReclutandoFase 3
- Research Site, Winston-Salem
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
ReclutandoFase 3
- Wake Forest University Health Sciences, Winston-Salem
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
ReclutandoFase 3
- Wake Forest University Baptist Medical Center, Winston-Salem
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
Reclutando
- Wake Forest University Health Sciences, Winston-Salem
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
ReclutandoFase 2
- Wake Forest University Health Sciences, Winston-Salem
Ensayos de Enfermedad cardiovascular en otras ciudades
- Boston, MA37 estudios
- New York City, NY33 estudios
- Washington, DC28 estudios
- Houston, TX24 estudios
- Dallas, TX23 estudios
- Atlanta, GA22 estudios
- Cleveland, OH22 estudios
- Chicago, IL21 estudios
- Philadelphia, PA21 estudios
- Pittsburgh, PA20 estudios
- St. Louis, MO20 estudios
- Nashville, TN18 estudios
Otros estudios en Winston-Salem
- Cáncer (todos los tipos)19 estudios
- Leucemia mielógena aguda18 estudios
- Mieloma múltiple14 estudios
- Cáncer de seno14 estudios
- Cáncer de pulmón de células no pequeñas12 estudios
- Enfermedad de obstrucción pulmonar crónica10 estudios
- Cáncer de ovario10 estudios
- Diabetes tipo 29 estudios
- Síndromes mielodisplásicos9 estudios
- Glioblastoma8 estudios
- Leucemia linfocítica crónica8 estudios
- Cáncer de pulmón8 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.